Evidence map›Paper›PMID 24935436›Full record

ArticleForensic science, medicine, and pathology2014

Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?

Mustafa Talip Sener, Emre Karakus, Zekai Halici, Erol Akpinar, Atilla Topcu, Ahmet Nezih Kok

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic science, medicine, and pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mustafa Talip SenerDepartment of Forensic Medicine, Ataturk University School of Medicine, 25240, Erzurum, Turkey, talipsener@gmail.com.
Emre Karakus
Zekai Halici
Erol Akpinar
Atilla Topcu
Ahmet Nezih Kok
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMyocardial infarction (MI) is one of the most prevalent causes of sudden adult death. It is difficult to diagnose early MI postmortem because there are no typical or characteristic changes in morphology. In this study, changes in the level of the mRNA for the urotensin receptor (UR) were investigated postmortem to determine the suitability of UR as a biomarker for diagnosis of early MI after death.

methodsAn MI rat model was developed by injecting rats with isoproterenol (ISO) (lethal dose 850 mg/kg) or normal saline (control group). The hearts of rats in the control and ISO-induced MI groups were harvested at 0, 1, 3, 6, 12, 24, 48, and 72 h (h) postmortem. The hearts were then immediately submerged in 1 mL of RNA stabilization solution and stored at 4 °C for <1 week before RNA extraction. Relative UR expression analysis was performed using the StepOne Plus Real Time PCR System with cDNA synthesized from rat heart.

resultsPostmortem UR mRNA expression was higher in the ISO-induced MI group than in the control group, at both 4 and 20 °C, at all of the time points examined except 72 h postmortem (p < 0.0001). The largest increases were observed at ambient temperature and 6 h postmortem.

conclusionsBased on our findings, increased postmortem UR expression could serve as a biomarker to aid diagnosis of early MI.

Indexed as

AnimalsAutopsyBiomarkersDisease Models, AnimalForensic GeneticsIsoproterenolMaleMyocardial InfarctionMyocardiumPostmortem ChangesPredictive Value of TestsRats, WistarReal-Time Polymerase Chain ReactionReceptors, Urokinase Plasminogen ActivatorRNA, MessengerTemperatureBiomarkersIsoproterenolPlaur protein, ratReceptors, Urokinase Plasminogen ActivatorRNA, Messenger

Identifiers

PMID24935436
OpenAlexW2004613275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.